Recent studies reveal elevated IL-6 levels strongly correlate with Alzheimer’s and mild cognitive impairment, highlighting inflammaging’s role and potential for lifestyle and drug interven...
Research shows muscularis macrophages in the gut trigger α-synuclein misfolding in Parkinson’s disease, spreading to the brain via immune pathways, with potential for early intervention through...
Recent studies reveal that cystathionine γ-lyase (CSE) deficiency accelerates brain aging via reduced hydrogen sulfide, offering new therapeutic avenues for neurodegenerative diseases. Groundbreaking...
Recent research shows compounds like P7C3-A20 restore NAD+ levels, reversing Alzheimer’s pathology in mice, with early clinical trials indicating safety and potential efficacy in humans. Breakth...
Recent studies reveal GSH-DNA adducts as critical mitochondrial DNA damage markers linked to aging and neurodegeneration, with new insights into repair mechanisms and therapeutic potentials. A breakth...
Recent research identifies OTULIN as a key regulator of tau in neurons, offering a novel approach for Alzheimer’s disease by modulating production instead of clearance, with potential for person...
A 2025 research paper finds that obese individuals with low choline levels face increased Alzheimer’s disease risk due to inflammation and neuronal damage, highlighting dietary interventions. Re...
New research links impaired glymphatic drainage to early cognitive decline, with DTI-ALPS imaging enabling early detection. Lifestyle interventions like sleep and exercise show promise in supporting b...
The Phase 3 failure of semaglutide in Alzheimer’s disease highlights challenges in repurposing GLP-1 agonists, urging a shift towards biomarker-driven and personalized approaches in neurodegener...
Recent research reveals osteoarthritis patients face a 25% higher risk of neurodegenerative diseases due to chronic inflammation, with practical strategies like diet and exercise offering protection. ...
